Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Alison Dawn Laws, M.D.

Concepts

This page shows the publications Alison Laws has written about Breast Neoplasms.
Connection Strength

1.438
  1. Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer. Oncology (Williston Park). 2021 Feb 11; 35(2):77-84.
    View in: PubMed
    Score: 0.138
  2. Implementation of a High-Risk Breast Clinic for Comprehensive Care of Women With Elevated Breast Cancer Risk Identified by Risk Assessment Models in the Community. JCO Oncol Pract. 2021 02; 17(2):e217-e225.
    View in: PubMed
    Score: 0.134
  3. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers. Ann Surg Oncol. 2020 Nov; 27(12):4819-4827.
    View in: PubMed
    Score: 0.133
  4. Baseline Screening MRI Uptake and Findings in Women with =?20% Lifetime Risk of Breast Cancer. Ann Surg Oncol. 2020 Oct; 27(10):3595-3602.
    View in: PubMed
    Score: 0.133
  5. Breast Biopsy During Post-treatment Surveillance of Screen-Detected Breast Cancer Patients Yields High Rates of Benign Findings. Ann Surg Oncol. 2020 Aug; 27(8):2689-2697.
    View in: PubMed
    Score: 0.129
  6. Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast Lesions. Ann Surg Oncol. 2019 Oct; 26(10):3361-3367.
    View in: PubMed
    Score: 0.124
  7. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Nov; 26(12):3846-3855.
    View in: PubMed
    Score: 0.123
  8. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ. J Surg Oncol. 2018 Dec; 118(7):1205-1211.
    View in: PubMed
    Score: 0.117
  9. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Ann Surg Oncol. 2018 Nov; 25(12):3548-3555.
    View in: PubMed
    Score: 0.116
  10. Intraoperative Margin Assessment in Wire-Localized Breast-Conserving Surgery for Invasive Cancer: A Population-Level Comparison of Techniques. Ann Surg Oncol. 2016 10; 23(10):3290-6.
    View in: PubMed
    Score: 0.100
  11. Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2021 Nov; 28(12):7347-7355.
    View in: PubMed
    Score: 0.035
  12. Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center. Breast Cancer Res Treat. 2021 Jan; 185(1):215-227.
    View in: PubMed
    Score: 0.034
  13. Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1358-1367.
    View in: PubMed
    Score: 0.033
  14. Same-Day Surgery for Mastectomy Patients in Alberta: A Perioperative Care Pathway and Quality Improvement Initiative. Ann Surg Oncol. 2019 Oct; 26(10):3354-3360.
    View in: PubMed
    Score: 0.031
  15. Margins in Breast-Conserving Surgery After Neoadjuvant Therapy. Ann Surg Oncol. 2018 Nov; 25(12):3541-3547.
    View in: PubMed
    Score: 0.029
  16. 'Driving' Rates Down: A Population-Based Study of Opening New Radiation Therapy Centers on the Use of Mastectomy for Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10):2994-3003.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.